ZA201805039B - Streptococcus uberis extract as an immunogenic agent - Google Patents

Streptococcus uberis extract as an immunogenic agent

Info

Publication number
ZA201805039B
ZA201805039B ZA2018/05039A ZA201805039A ZA201805039B ZA 201805039 B ZA201805039 B ZA 201805039B ZA 2018/05039 A ZA2018/05039 A ZA 2018/05039A ZA 201805039 A ZA201805039 A ZA 201805039A ZA 201805039 B ZA201805039 B ZA 201805039B
Authority
ZA
South Africa
Prior art keywords
extract
immunogenic agent
streptococcus uberis
uberis
streptococcus
Prior art date
Application number
ZA2018/05039A
Other languages
English (en)
Inventor
Gimbert Rosa Maria Collado
I Amargós Antoni Prenafeta
Original Assignee
Hipra Scient S L U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hipra Scient S L U filed Critical Hipra Scient S L U
Publication of ZA201805039B publication Critical patent/ZA201805039B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA2018/05039A 2016-02-15 2018-07-26 Streptococcus uberis extract as an immunogenic agent ZA201805039B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382060 2016-02-15
PCT/EP2017/053306 WO2017140683A2 (en) 2016-02-15 2017-02-14 Streptococcus uberis extract as an immunogenic agent

Publications (1)

Publication Number Publication Date
ZA201805039B true ZA201805039B (en) 2020-05-27

Family

ID=55646514

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2018/05039A ZA201805039B (en) 2016-02-15 2018-07-26 Streptococcus uberis extract as an immunogenic agent

Country Status (11)

Country Link
US (1) US10946085B2 (enExample)
EP (1) EP3417049B1 (enExample)
JP (1) JP6839199B2 (enExample)
KR (1) KR102824686B1 (enExample)
AU (1) AU2017220528A1 (enExample)
CA (1) CA3012419A1 (enExample)
ES (1) ES2960326T3 (enExample)
MX (1) MX387200B (enExample)
PL (1) PL3417049T3 (enExample)
WO (1) WO2017140683A2 (enExample)
ZA (1) ZA201805039B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022352157A1 (en) 2021-09-21 2024-05-02 National Agriculture And Food Research Organization Vaccine including nonencapsulated strain as antigen
EP4570265A1 (en) 2023-12-15 2025-06-18 Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. Vaccine for use in preventing inflammatory conditions in cows

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243024A (ja) * 1983-12-29 1985-12-03 Kitasato Inst:The ストレプトコツカス・サンギス感染症予防用ワクチン,診断用抗原および抗体
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2222701C (en) 1995-06-08 2012-02-07 University Of Saskatchewan Camp factor of streptococcus uberis
DK1332155T3 (da) 2000-06-12 2007-02-26 Univ Saskatchewan Vaccination af malkekvæg med GapC protein mod streptokokinfektion
US20070231335A1 (en) * 2005-07-20 2007-10-04 Bruce Beutler Compositions and methods for treating Gram positive bacterial infection in a mammalian subject
US8273361B2 (en) 2006-09-26 2012-09-25 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US20110028407A1 (en) * 2007-02-09 2011-02-03 Jutila Mark A Enhancement of innate resistance to infection
GB0818231D0 (en) 2008-10-06 2008-11-12 Univ Nottingham Composition
EP3461496B1 (en) * 2009-06-22 2023-08-23 Wyeth LLC Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
WO2012116447A1 (en) 2011-03-03 2012-09-07 The Governors Of The University Of Alberta Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
MX2013013182A (es) 2011-05-12 2013-12-09 Intervet Int Bv Tratamiento de la mastitis.
BR112013032675A2 (pt) * 2011-06-19 2017-08-08 Vaxine Pty Ltd composição adjuvante de vacina compreendendo partículas de inulina
WO2015042423A2 (en) 2013-09-19 2015-03-26 Zoetis Llc Vaccine

Also Published As

Publication number Publication date
KR102824686B1 (ko) 2025-06-25
EP3417049A2 (en) 2018-12-26
PL3417049T3 (pl) 2024-02-19
CA3012419A1 (en) 2017-08-24
WO2017140683A2 (en) 2017-08-24
JP6839199B2 (ja) 2021-03-03
ES2960326T3 (es) 2024-03-04
MX387200B (es) 2025-03-18
US20190038736A1 (en) 2019-02-07
MX2018009048A (es) 2019-03-28
KR20180108619A (ko) 2018-10-04
JP2019504623A (ja) 2019-02-21
AU2017220528A1 (en) 2018-08-09
EP3417049B1 (en) 2023-08-16
BR112018015255A2 (pt) 2018-12-18
WO2017140683A3 (en) 2017-10-12
US10946085B2 (en) 2021-03-16

Similar Documents

Publication Publication Date Title
ZA201807203B (en) Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
ZA201607627B (en) Vaccine composition against streptococcus suis infection
PL3442480T3 (pl) Sposób podawania miejscowego
EP3129357A4 (en) Affinity medicant conjugates
GB201610599D0 (en) Immunogenic Composition
GB201711635D0 (en) Immunogenic composition
GB201518668D0 (en) Immunogenic Comosition
IL251120B (en) Immunogenic/therapeutic glycoside preparations and their uses
ZA201608487B (en) Dual adjuvant vaccine compositions, preparation and uses
EP3397277C0 (en) IMMUNOGENIC COMPOSITION
EP3138575A4 (en) Freeze-dried hgf preparation
GB201711637D0 (en) Immunogenic composition
GB201614485D0 (en) Immunogenic composition
ZA201805039B (en) Streptococcus uberis extract as an immunogenic agent
GB201604755D0 (en) Immunogenic compositions
ZA201605935B (en) Topical antibiotic formulations
EP3135292A4 (en) Antiobesity agent containing walnut extract
GB201911959D0 (en) Immunogenic compositions and uses therefor
IL252955A0 (en) Compounds for mouthwash
EP3284472A4 (en) Hot flash-suppressing agent
SG11201607464QA (en) Prophylactic agent for pneumococcal infection
HK40007612A (en) Immunogenic composition
GB2547074B (en) Rotary introducer
GB201501153D0 (en) Immunogenic formulations
AU2015901802A0 (en) Extract